115 related articles for article (PubMed ID: 3284834)
1. Structure-conformation relationships of synthetic peptide inhibitors of human renin studied by resonance energy transfer and molecular modeling.
Epps DE; Mao B; Staples DJ; Sawyer TK
Int J Pept Protein Res; 1988 Jan; 31(1):22-34. PubMed ID: 3284834
[TBL] [Abstract][Full Text] [Related]
2. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
3. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
TenBrink RE; Pals DT; Harris DW; Johnson GA
J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
[TBL] [Abstract][Full Text] [Related]
6. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
[TBL] [Abstract][Full Text] [Related]
7. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
Johnson RL; Verschoor K
J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
[TBL] [Abstract][Full Text] [Related]
9. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
[TBL] [Abstract][Full Text] [Related]
10. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human renin by synthetic peptides derived from its prosegment.
Cumin F; Evin G; Fehrentz JA; Seyer R; Castro B; Menard J; Corvol P
J Biol Chem; 1985 Aug; 260(16):9154-7. PubMed ID: 3894354
[TBL] [Abstract][Full Text] [Related]
12. On the specificity of human renin. Studies with peptide inhibitors.
Poulsen K; Haber E; Burton J
Biochim Biophys Acta; 1976 Dec; 452(2):533-7. PubMed ID: 1009126
[TBL] [Abstract][Full Text] [Related]
13. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors of human renin. Cyclic peptides based on the tetrapeptide sequence Glu-D-Phe-Lys-D-Trp.
Dutta AS; Gormley JJ; McLachlan PF; Major JS
J Med Chem; 1990 Sep; 33(9):2552-60. PubMed ID: 2202828
[TBL] [Abstract][Full Text] [Related]
17. Conformations of synthetic tetradecapeptide renin substrate and of angiotensin I in aqueous solution.
Oliveira MC; Juliano L; Paiva AC
Biochemistry; 1977 Jun; 16(12):2606-11. PubMed ID: 19034
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
20. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
